Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958472 · ClinicalTrials.gov registry record
Navigating the Clinical Research Process for Glioma
A clinical trial, sponsored by Power Life Sciences.
- Not yet
- Registry status
- 500
- Enrollment target
NCT05958472 is a clinical trial that has not yet begun recruiting, run by Power Life Sciences. The registered enrollment target is 500 participants.
The verdict
NCT05958472 has not yet begun recruiting, sponsored by Power Life Sciences.
- NOT YET RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of glioma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future glioma patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-08 |
| Est. Completion | 2026-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05958472
The ClinicalTrials.gov registry entry for NCT05958472 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Power Life Sciences, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05958472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05958472 about?
NCT05958472 is a clinical study titled "Navigating the Clinical Research Process for Glioma". Participation in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This trial will admit a wide range of data on the clinical trial experience of glioma p...
What is the current status of trial NCT05958472?
This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2024-08. Estimated completion is 2026-08.
Who is sponsoring clinical trial NCT05958472?
This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.